Search

everythinglearnresearchcommunity

for

Search:↓

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

New treatments for male hypogonadism are effective and should be personalized.

Scientists found new nonsteroidal compounds that can act like natural male hormones and might help treat male fertility and hormone issues.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Mutations in certain receptors can cause diseases and offer new treatment options.

SARM-induced changes in the androgen receptor are specific to each ligand and affect stability and protein interactions.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Finasteride may improve prostate cancer treatment outcomes.

A 12-year-old boy with PAIS successfully developed male characteristics using high-dose testosterone and anastrozole.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Compounds from the Sansevieria trifasciata plant might be effective for treating hair loss.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Analog 23 is a promising compound for prostate cancer treatment.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Bicalutamide may help treat female pattern hair loss.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.